A Screening Study for the Development of Simvastatin-Doxorubicin Liposomes, a Co-Formulation with Future Perspectives in Colon Cancer Therapy

• Main Authors: Cristina Ioana Barbălată (Author), Alina Silvia Porfire (Author), Alina Sesarman (Author), Valentin-Florian Rauca (Author), Manuela Banciu (Author), Dana Muntean (Author), Rareș Știufiuc (Author), Alin Moldovan (Author), Cristian Moldovan (Author), Ioan Tomuță (Author)
• Format: Book
• Published: MDPI AG, 2021-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

An increasing number of studies published so far have evidenced the benefits of Simvastatin (SIM) and Doxorubicin (DOX) co-treatment in colorectal cancer. In view of this, the current study aimed to investigate the pharmaceutical development of liposomes co-encapsulating SIM and DOX, by implementing...